Literature DB >> 8939609

Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways.

K Reif1, C D Nobes, G Thomas, A Hall, D A Cantrell.   

Abstract

BACKGROUND: Phosphatidylinositol 3'-hydroxyl kinase (PI 3-kinase) is activated by many growth factor receptors and is thought to exert its cellular functions through the elevation of phosphatidylinositol (3,4,5)-triphosphate levels in the cell. PI 3-kinase is required for growth-factor induced changes of the actin cytoskeleton which are mediated by the GTPases Rac and Rho. Recently, a role for Rac and Rho in regulating gene transcription has become evident.
RESULTS: Here, we show that membrane targeting of the p110 catalytic subunit, but not the p85 regulatory subunit, of PI 3-kinase generates a constitutively active enzyme that allows us to assess the relative contribution of PI 3-kinase activation to a particular cellular response. Expression of this active PI 3-kinase induced actin reorganization in the form of Rac-mediated lamellipodia and focal complexes, and Rho-mediated stress fibres and focal adhesions. However, expression of active PI 3-kinase did not induce the Ras/Rac/Rho signalling pathways that regulate gene transcription controlled by the c-fos promoter, the c-fos serum response element or the transcription factors Elk-1 and AP-1.
CONCLUSIONS: Our results demonstrate that PI 3-kinase induces a selective subset of cellular responses, but is not sufficient to stimulate the full repertoire of Rac- or Rho-mediated responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939609     DOI: 10.1016/s0960-9822(96)00749-x

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  63 in total

1.  Phosphatidylinositol 3-kinase, Cdc42, and Rac1 act downstream of Ras in integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells.

Authors:  S Sarner; R Kozma; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Small GTPases in lymphocyte biology: Rho proteins take center stage.

Authors:  S Henning; S Cleverley
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  T-cell antigen receptor signal transduction.

Authors:  Doreen A Cantrell
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

Review 4.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

5.  Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling.

Authors:  Qize Wei; Robert S Adelstein
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

6.  Integrating signals from T-cell receptor and serum by T cells enhance translation of tumour necrosis factor-alpha.

Authors:  M Buxadé; M Ramírez-Alvarado; N Fernández-Troy; S MacKenzie; R P Casaroli-Marano; R Vilella; E Espel
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

7.  PI3K and Erk MAPK mediate ErbB signaling in Xenopus gastrulation.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Mech Dev       Date:  2007-07-19       Impact factor: 1.882

Review 8.  Recent advances in the understanding of interleukin-2 signal transduction.

Authors:  F Gesbert; M Delespine-Carmagnat; J Bertoglio
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

9.  Inositide signalling in Chlamydomonas: characterization of a phosphatidylinositol 3-kinase gene.

Authors:  A J Molendijk; R F Irvine
Journal:  Plant Mol Biol       Date:  1998-05       Impact factor: 4.076

10.  Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1.

Authors:  Ian N Fleming; Ian H Batty; Alan R Prescott; Alex Gray; Gursant S Kular; Hazel Stewart; C Peter Downes
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.